Comparing outcomes of hospitalized patients with moderate and severe COVID-19 following treatment with hydroxychloroquine plus atazanavir/ritonavir

BACKGROUND: The role of the antiviral therapy in treatment of COVID-19 is still a matter to be investigated. Also efficacy and safety of antiviral regimens were not compared according severity of the disease. In this study the efficacy and safety of hydroxychloroquine plus atazanavir/ritonavir was c...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahmani, Hamid, Davoudi-Monfared, Effat, Nourian, Anahid, Nabiee, Morteza, Sadeghi, Setayesh, Khalili, Hossein, Abbasian, Ladan, Ghiasvand, Fereshteh, Seifi, Arash, Hasannezhad, Malihe, Ghaderkhani, Sara, Mohammadi, Mostafa, Yekaninejad, Mir Saeed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453126/
https://www.ncbi.nlm.nih.gov/pubmed/32857301
http://dx.doi.org/10.1007/s40199-020-00369-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453126/
https://www.ncbi.nlm.nih.gov/pubmed/32857301
http://dx.doi.org/10.1007/s40199-020-00369-2

Ejemplares similares